Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Gross Profit (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed Gross Profit for 3 consecutive years, with $6174.0 as the latest value for Q1 2018.

  • Quarterly Gross Profit changed N/A to $6174.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $6174.0 through Dec 2018, down 96.55% year-over-year, with the annual reading at $6174.0 for FY2018, 96.55% down from the prior year.
  • Gross Profit for Q1 2018 was $6174.0 at ENDRA Life Sciences, up from $3765.0 in the prior quarter.
  • The five-year high for Gross Profit was $279704.0 in Q4 2016, with the low at $3765.0 in Q4 2017.
  • Average Gross Profit over 3 years is $92943.6, with a median of $6345.0 recorded in 2017.
  • Peak annual rise in Gross Profit hit 98.65% in 2017, while the deepest fall reached 98.65% in 2017.
  • Over 3 years, Gross Profit stood at $279704.0 in 2016, then crashed by 98.65% to $3765.0 in 2017, then soared by 63.98% to $6174.0 in 2018.
  • According to Business Quant data, Gross Profit over the past three periods came in at $6174.0, $3765.0, and $168730.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.